Vanda Pharmaceuticals announced its NEREUS™ branded No. 47 car, driven by Mick Schumacher, will compete in the inaugural Freedom 250 Grand Prix on Washington D.C.'s National Mall. The race celebrates America's 250th anniversary with a 147-lap event on a temporary street circuit near iconic landmarks. NEREUS™, a new medication for motion-induced vomiting, is the primary sponsor, aligning with the brand's focus on performance. The event marks a significant promotional moment for Vanda, a Washington-based biopharmaceutical company, as it highlights its innovative product in a high-profile sporting event.
Tesla has increased its control of the U.S. electric vehicle (EV) market to 59%, marking its highest market share since 2023. This growth highlights Tesla's strong position and continued dominance in the competitive EV industry. The increased market ...
Aave's total deposits have surged to $30 billion, marking a 30% increase in Q3 2026 and signaling a recovery in liquidity for the DeFi lending platform. Active loans stand at about $10 billion, showing significant capital use within the ecosystem. Th...
The memecoin PEPE surged 61% over the past week, driven by strong buying pressure and a 123% increase in daily trading volume. Despite the impressive rally, technical indicators and a bearish swing structure on the daily chart suggest caution. The ra...
South Korea's Upbit exchange recorded a massive $830 million in trading volume within a single hour, driven mainly by XRP and TRUMP tokens. This spike follows a 273% daily volume increase on August 21, marking a rebound after months of weaker activit...
Last week, US-listed Bitcoin and Ethereum exchange-traded funds (ETFs) recorded their largest weekly inflows since October 2025, attracting a combined $2.6 billion. Bitcoin ETFs led with $1.92 billion, while Ethereum ETFs added $697 million, reversin...
